PUBLIC CONTRACT · 2018
Fornecimento de Ceritinib, Ranibizumab, Secucinumab, Omalizumab e Octreotido ao HSEIT, EPER
- Contract value
- €234,887.54
- Signed on
- 14 March 2018
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 4715108PUBLISHED DESCRIPTION
Contrato no 39/2018
Parties involved
- Awardee
- - - NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA
- Place of performance
- Portugal, Região Autónoma dos Açores, Angra do Heroismo
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- - - NOVARTIS FARMA-PRODUT.FARMACEUTICOS, SA
- Bidder
- NOVARTIS FARMA-PROD.FARMACÊUTICOS,SA. · Tax ID 500063524
Values and timeline
- Contract price
- €234,887.54
- Procedure base price
- €242,125.97
- Total effective price
- €193,302.88
- Publication date
- 3 August 2018
- Award date
- 31 January 2018
- Signing date
- 14 March 2018
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
- Legal basis
- Artigo 24.º, n.º 1, alínea e) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos e DLR no 27/2015/A, de 29.12
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3186348
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.